Patrick Clarence Machado

Affiliations

  • at Adverum Biotechnologies Inc. (ADVM), 2025-06-20
  • Director at Arcus Biosciences Inc. (RCUS), 2025-06-12
  • at Xenon Pharmaceuticals Inc. (XENE), 2025-06-06
  • Director at Acelyrin Inc. (SLRN), 2025-05-23
  • at Alumis Inc. (ALMS), 2025-05-23
  • Director at Turnstone Biologics Corp. (TSBX), 2023-07-21
  • Director at Chimerix Inc (CMRX), 2023-06-12
  • Director at Turning Point Therapeutics Inc. (TPTX), 2022-08-17
  • Director at Roivant Sciences Ltd. (ROIV), 2021-10-01
  • Director at Principia Biopharma Inc. (PRNB), 2020-09-28
  • Other at Arbutus Biopharma Corp (ABUS), 2019-07-16
  • Other at Myovant Sciences Ltd. (MYOV), 2019-07-16
  • Other at Axovant Gene Therapies Ltd. (AXON), 2019-07-16
  • Other at Urovant Sciences Ltd. (UROV), 2019-07-16
  • Director at Scynexis Inc (SCYX), 2019-01-04
  • Director at Endocyte Inc (ECYT), 2018-12-21
  • Director at Inotek Pharmaceuticals Corp (ITEK), 2017-06-21
  • Director at Medivation Inc. (MDVN), 2016-09-30
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ADVM $9.92 10,000 $99,196.00 88,182 2021-03-24 Filing
ADVM $11.52 10,000 $115,174.00 78,182 2021-01-15 Filing
UROV $8.17 4,957 $40,495.22 22,860,013 2019-06-19 Filing
UROV $8.21 6,706 $55,060.95 22,855,056 2019-06-18 Filing
UROV $8.53 6,541 $55,824.82 22,848,350 2019-06-17 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MDVN $39.19 6,950 $272,370.50 66,156 2016-01-19 Filing
MDVN $38.62 7,942 $306,720.04 73,106 2016-01-19 Filing
MDVN $37.50 23,087 $865,762.50 81,048 2016-01-19 Filing
MDVN $36.62 37,021 $1,355,709.02 104,135 2016-01-19 Filing
MDVN $43.92 17,680 $776,505.60 66,156 2015-09-25 Filing